The potential of T-cell engagers in SCLC treatment

Education and training in breast cancer care

EAU 2026: Updates in NMIBC

Microplastics found at higher levels in prostate cancer tissue compared to benign tissue

Belzutifan plus palbociclib shows modest activity with manageable safety in heavily pretreated kidney cancer

HIF-2α inhibitor Cas shows durable responses and biomarker-linked benefit in metastatic kidney cancer

QoL outcomes are inconsistently reported in contemporary phase III genitourinary cancer trials

The Vanessa Moss Prize: celebrating research into cancer health disparities

Can public–private partnerships accelerate cancer research and clinical trials in LMICs?

Global cancer burden, prevention, and inequalities across regions

Understanding breast cancer care systems with the BCCi

Strengthening cancer prevention through the Latin American cancer code